{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:56:24Z","timestamp":1781225784267,"version":"3.54.1"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Decompensated heart failure accounts for approximately 1 million hospitalizations in the United States annually, and this number is expected to increase significantly in the near future. Diuretics provide the initial management in most patients with fluid overload. However, the development of diuretic resistance remains a significant challenge in the treatment of heart failure. Due to the lack of a standard definition, the prevalence of this phenomenon remains difficult to determine, with some estimates suggesting that 25\u201330% of patients with heart failure have diuretic resistance. Certain characteristics, including low systolic blood pressures, renal impairment, and atherosclerotic disease, help predict the development of diuretic resistance. The underlying pathophysiology is likely multifactorial, with pharmacokinetic alterations, hormonal dysregulation, and the cardiorenal syndrome having significant roles. The therapeutic approach to this common problem typically involves increases in the diuretic dose and\/or frequency, sequential nephron blockade, and mechanical fluid movement removal with ultrafiltration or peritoneal dialysis. Paracentesis is potentially useful in patients with intra-abdominal hypertension.<\/jats:p>","DOI":"10.1097\/crd.0000000000000310","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T08:53:57Z","timestamp":1586768037000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Diuretic Resistance in Heart Failure"],"prefix":"10.1097","volume":"29","author":[{"given":"Rubayat","family":"Rahman","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Paz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elmassry","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mantilla","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Dobbe","sequence":"additional","affiliation":[{"name":"Department of Graduate Medical Education, Madigan Army Medical Center, Tacoma, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Shurmur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Nugent","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"R2-20250619","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2010.03.019","article-title":"Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data.","volume":"159","author":"Sato","year":"2010","journal-title":"Am Heart J"},{"key":"R3-20250619","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.","volume":"60","author":"Ronco","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250619","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure.","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/CNQ.0000000000000173","article-title":"Diuretic resistance in acute decompensated heart failure: a challenging clinical conundrum.","volume":"40","author":"Reed","year":"2017","journal-title":"Crit Care Nurs Q"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9343(98)00365-9","article-title":"Diuretic treatment and diuretic resistance in heart failure.","volume":"106","author":"Kr\u00e4mer","year":"1999","journal-title":"Am J Med"},{"key":"R7-20250619","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.","volume":"12","author":"ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","article-title":"Sequential nephron blockade breaks resistance to diuretics in edematous states.","volume":"29","author":"Knauf","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12245-017-0143-x","article-title":"Markers of diuretic resistance in emergency department patients with acute heart failure.","volume":"10","author":"Doering","year":"2017","journal-title":"Int J Emerg Med"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance.","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"key":"R11-20250619","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.ASN.0000018409.45834.FA","article-title":"Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study.","volume":"13","author":"McClellan","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 3","key":"R12-20250619","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-199100413-00008","article-title":"The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.","volume":"41","author":"Risler","year":"1991","journal-title":"Drugs"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure.","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"R14-20250619","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ki.1982.149","article-title":"Absorption and disposition of furosemide in congestive heart failure.","volume":"22","author":"Brater","year":"1982","journal-title":"Kidney Int"},{"key":"R15-20250619","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00003495-198530050-00003","article-title":"Resistance to loop diuretics. Why it happens and what to do about it.","volume":"30","author":"Brater","year":"1985","journal-title":"Drugs"},{"key":"R16-20250619","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcrc.2013.10.004","article-title":"Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis.","volume":"29","author":"Kitsios","year":"2014","journal-title":"J Crit Care"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ejhf.815","article-title":"The complexity of diuretic resistance.","volume":"19","author":"Aronson","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1753944717718717","article-title":"A perspective on diuretic resistance in chronic congestive heart failure.","volume":"11","author":"Shah","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/bmj.289.6457.1492","article-title":"Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension.","volume":"289","author":"Koopmans","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/18.1.41","article-title":"Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.","volume":"18","author":"Cleland","year":"1997","journal-title":"Eur Heart J"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0733-8651(05)70246-0","article-title":"Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?","volume":"19","author":"Hall","year":"2001","journal-title":"Cardiol Clin"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.73.2.257","article-title":"Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.","volume":"73","author":"Lee","year":"1986","journal-title":"Circulation"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-110-1-24","article-title":"Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis.","volume":"110","author":"Friedman","year":"1989","journal-title":"Ann Intern Med"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(82)90576-9","article-title":"Antidiuretic hormone in congestive heart failure.","volume":"72","author":"Riegger","year":"1982","journal-title":"Am J Med"},{"key":"R26-20250619","first-page":"450","article-title":"Response of the kidney to furosemide. I. Effects of salt intake and renal compensation.","volume":"102","author":"Wilcox","year":"1983","journal-title":"J Lab Clin Med"},{"key":"R27-20250619","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/pmj.79.931.268","article-title":"Mechanisms and management of diuretic resistance in congestive heart failure.","volume":"79","author":"De Bruyne","year":"2003","journal-title":"Postgrad Med J"},{"key":"R28-20250619","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1172\/JCI107432","article-title":"Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron.","volume":"52","author":"Edwards","year":"1973","journal-title":"J Clin Invest"},{"key":"R29-20250619","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","article-title":"Mechanism of impaired natriuretic response to furosemide during prolonged therapy.","volume":"36","author":"Loon","year":"1989","journal-title":"Kidney Int"},{"key":"R30-20250619","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.CIR.42.2.323","article-title":"Influence of sodium balance on the ability of diuretics to inhibit tubular reabsorption. A study of factors that influence renal tubular sodium reabsorption in man.","volume":"42","author":"Earley","year":"1970","journal-title":"Circulation"},{"key":"R31-20250619","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1113\/expphysiol.1990.sp003412","article-title":"The effect of loop diuretics on fluid reabsorption from the rat proximal convoluted tubule.","volume":"75","author":"Greenwood","year":"1990","journal-title":"Exp Physiol"},{"key":"R32-20250619","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.ackd.2018.08.004","article-title":"Cardiorenal syndrome: an overview.","volume":"25","author":"Ronco","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"R33-20250619","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11897-014-0218-4","article-title":"The acute cardiorenal syndrome: burden and mechanisms of disease.","volume":"11","author":"Nijst","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"R34-20250619","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jacc.2011.01.054","article-title":"Blood urea nitrogen a marker for adverse effects of loop diuretics?","volume":"58","author":"Lindenfeld","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R35-20250619","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cardfail.2007.02.005","article-title":"Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.","volume":"13","author":"Filippatos","year":"2007","journal-title":"J Card Fail"},{"key":"R36-20250619","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.amjcard.2008.01.047","article-title":"Relation of blood urea nitrogen to long-term mortality in patients with heart failure.","volume":"101","author":"Cauthen","year":"2008","journal-title":"Am J Cardiol"},{"key":"R37-20250619","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2011.01.052","article-title":"Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure.","volume":"58","author":"Testani","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R38-20250619","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/eurjhf\/hfs090","article-title":"Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.","volume":"14","author":"N\u00fa\u00f1ez","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"3 pt 2","key":"R39-20250619","first-page":"F374","article-title":"Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment.","volume":"248","author":"Kaissling","year":"1985","journal-title":"Am J Physiol"},{"key":"R40-20250619","doi-asserted-by":"crossref","first-page":"F133","DOI":"10.1152\/ajprenal.00227.2002","article-title":"Upregulation of Na+ transporter abundances in response to chronic thiazide or loop diuretic treatment in rats.","volume":"284","author":"Na","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"R41-20250619","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1681\/ASN.2015121312","article-title":"Small-molecule inhibitors of pendrin potentiate the diuretic action of furosemide.","volume":"27","author":"Cil","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R42-20250619","doi-asserted-by":"crossref","first-page":"e79327","DOI":"10.1371\/journal.pone.0079327","article-title":"Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications.","volume":"8","author":"Zahedi","year":"2013","journal-title":"PLoS One"},{"key":"R43-20250619","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome.","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R44-20250619","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","article-title":"Abdominal contributions to cardiorenal dysfunction in congestive heart failure.","volume":"62","author":"Verbrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R45-20250619","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.","volume":"53","author":"Damman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R46-20250619","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R47-20250619","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2013.09.014","article-title":"Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction.","volume":"169","author":"Guazzi","year":"2013","journal-title":"Int J Cardiol"},{"key":"R48-20250619","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R49-20250619","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"key":"R50-20250619","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10741-018-09768-9","article-title":"Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.","volume":"24","author":"Agrawal","year":"2019","journal-title":"Heart Fail Rev"},{"key":"R51-20250619","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/clc.22489","article-title":"Intra-abdominal hypertension: an important consideration for diuretic resistance in acute decompensated heart failure.","volume":"39","author":"Nguyen","year":"2016","journal-title":"Clin Cardiol"},{"issue":"2 pt 2","key":"R52-20250619","first-page":"R208","article-title":"Cardiovascular responses to elevation of intra-abdominal hydrostatic pressure.","volume":"248","author":"Barnes","year":"1985","journal-title":"Am J Physiol"},{"key":"R53-20250619","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.ccx.0000155355.86241.1b","article-title":"Intra-abdominal hypertension in the critically ill: it is time to pay attention.","volume":"11","author":"Malbrain","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"R54-20250619","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?","volume":"51","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R55-20250619","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cardfail.2008.02.010","article-title":"Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure.","volume":"14","author":"Mullens","year":"2008","journal-title":"J Card Fail"},{"key":"R56-20250619","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CRD.0000000000000116","article-title":"Treating diuretic resistance: an overview.","volume":"24","author":"Bowman","year":"2016","journal-title":"Cardiol Rev"},{"key":"R57-20250619","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","article-title":"Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study.","volume":"162","author":"Feenstra","year":"2002","journal-title":"Arch Intern Med"},{"key":"R58-20250619","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1988.00380020030006","article-title":"High-dose furosemide in the treatment of refractory congestive heart failure.","volume":"148","author":"Gerlag","year":"1988","journal-title":"Arch Intern Med"},{"key":"R59-20250619","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1378\/chest.102.3.725","article-title":"Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure.","volume":"102","author":"Lahav","year":"1992","journal-title":"Chest"},{"key":"R60-20250619","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.1994.tb01082.x","article-title":"Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.","volume":"235","author":"van Meyel","year":"1994","journal-title":"J Intern Med"},{"key":"R61-20250619","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.","volume":"28","author":"Dormans","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R62-20250619","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0030-6665(20)30770-2","article-title":"Ototoxicity of loop diuretics.","volume":"26","author":"Rybak","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"key":"R63-20250619","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","article-title":"Diuretics and ultrafiltration in acute decompensated heart failure.","volume":"59","author":"Felker","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R64-20250619","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/hrt.2005.079764","article-title":"Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"key":"R65-20250619","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.","volume":"43","author":"L\u00f3pez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R66-20250619","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2459\/JCM.0000000000000794","article-title":"Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.","volume":"20","author":"Miles","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R67-20250619","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/fca.15.56","article-title":"Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.","volume":"11","author":"Mentz","year":"2015","journal-title":"Future Cardiol"},{"key":"R68-20250619","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FJC.0000000000000212","article-title":"Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.","volume":"65","author":"Mentz","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"R69-20250619","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amjcard.2015.10.059","article-title":"Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF Trial).","volume":"117","author":"Mentz","year":"2016","journal-title":"Am J Cardiol"},{"key":"R70-20250619","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0140-6736(90)90148-X","article-title":"Metolazone in treatment of severe refractory congestive cardiac failure.","volume":"335","author":"Kiyingi","year":"1990","journal-title":"Lancet"},{"key":"R71-20250619","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/oxfordjournals.eurheartj.a014805","article-title":"Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.","volume":"17","author":"Dormans","year":"1996","journal-title":"Eur Heart J"},{"key":"R72-20250619","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/hrt.71.2.146","article-title":"Combination diuretic treatment in severe heart failure: a randomised controlled trial.","volume":"71","author":"Channer","year":"1994","journal-title":"Br Heart J"},{"key":"R73-20250619","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure.","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"R74-20250619","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"R75-20250619","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1253\/circj.CJ-17-0179","article-title":"Effects of additive tolvaptan vs. increased furosemide on heart failure with diuretic resistance and renal impairment\u2014results from the K-STAR Study.","volume":"82","author":"Inomata","year":"2017","journal-title":"Circ J"},{"key":"R76-20250619","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cardfail.2007.10.006","article-title":"Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: the ECLIPSE International, multicenter, randomized, placebo-controlled trial.","volume":"13","author":"Udelson","year":"2007","journal-title":"J Card Failure"},{"key":"R77-20250619","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12872-017-0598-y","article-title":"Effects of tolvaptan in patients with acute heart failure: a systematic review and meta-analysis.","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"R78-20250619","first-page":"157","article-title":"Diuretic strategies for loop diuretic resistance in acute heart failure.","volume":"8","author":"Cox","year":"2020","journal-title":"JACC: Heart Failure"},{"key":"R79-20250619","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure.","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"R80-20250619","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11936-015-0436-4","article-title":"Management of cardio-renal syndrome and diuretic resistance.","volume":"18","author":"Verbrugge","year":"2016","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"R81-20250619","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.","volume":"71","author":"van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"key":"R82-20250619","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(03)00188-0","article-title":"Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.","volume":"39","author":"Santos","year":"2003","journal-title":"J Hepatol"},{"key":"R83-20250619","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial.","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"R84-20250619","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the dopamine in acute decompensated heart failure (DAD-HF) trial.","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J Card Fail"},{"key":"R85-20250619","doi-asserted-by":"crossref","first-page":"e002593","DOI":"10.1161\/CIRCHEARTFAILURE.115.002593","article-title":"Differential response to low-dose dopamine or low-dose nesiritide in acute heart failure with reduced or preserved ejection fraction.","volume":"9","author":"Wan","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"suppl 1","key":"R86-20250619","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ihj.2015.10.386","article-title":"Decongestion: diuretics and other therapies for hospitalized heart failure.","volume":"68","author":"Vazir","year":"2016","journal-title":"Indian Heart J"},{"key":"R87-20250619","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.107.737106","article-title":"Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action.","volume":"117","author":"Elkayam","year":"2008","journal-title":"Circulation"},{"key":"R88-20250619","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","article-title":"Diuretic response in acute heart failure-an analysis from ASCEND-HF.","volume":"170","author":"ter Maaten","year":"2015","journal-title":"Am Heart J"},{"key":"R89-20250619","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure.","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"R90-20250619","doi-asserted-by":"crossref","first-page":"E563","DOI":"10.1016\/S0735-1097(13)60563-X","article-title":"Predictors of urine output and the effects of nesiritide in acute decompensated heart failure: results from ASCEND-HF.","volume":"61","author":"Gottlieb","year":"2013","journal-title":"J Am Coll Card"},{"key":"R91-20250619","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"R92-20250619","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00059-013-4041-6","article-title":"Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: a meta-analysis of the literature.","volume":"40","author":"De Vecchis","year":"2015","journal-title":"Herz"},{"key":"R93-20250619","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.","volume":"145","author":"Licata","year":"2003","journal-title":"Am Heart J"},{"key":"R94-20250619","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(00)00094-5","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.","volume":"2","author":"Paterna","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"R95-20250619","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","article-title":"Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).","volume":"342","author":"Paterna","year":"2011","journal-title":"Am J Med Sci"},{"key":"R96-20250619","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R97-20250619","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome.","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"R98-20250619","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/jcaf.2003.28","article-title":"Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients.","volume":"9","author":"Jaski","year":"2003","journal-title":"J Card Fail"},{"key":"R99-20250619","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.cardfail.2004.06.018","article-title":"Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: preliminary report of the rapid trial.","volume":"10","author":"Bart","year":"2004","journal-title":"J Card Failure"},{"key":"R100-20250619","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R101-20250619","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/eurjhf\/hfq207","article-title":"Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study.","volume":"13","author":"Giglioli","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"R102-20250619","doi-asserted-by":"crossref","first-page":"378","DOI":"10.11622\/smedj.2016014","article-title":"Ultrafiltration in patients with decompensated heart failure and diuretic resistance: an Asian centre\u2019s experience.","volume":"57","author":"Teo","year":"2016","journal-title":"Singapore Med J"},{"key":"R103-20250619","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00000441-194907000-00011","article-title":"Continuous peritoneal irrigation in the treatment of intractable edema of cardiac origin.","volume":"218","author":"Schneierson","year":"1949","journal-title":"Am J Med Sci"},{"key":"R104-20250619","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000321102","article-title":"Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure.","volume":"30","author":"Cnossen","year":"2010","journal-title":"Blood Purif"},{"key":"R105-20250619","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/eurjhf\/hfs035","article-title":"Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease.","volume":"14","author":"Koch","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"R106-20250619","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ndt\/gfp484","article-title":"Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure.","volume":"25","author":"S\u00e1nchez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R107-20250619","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3747\/pdi.2012.00149","article-title":"Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics.","volume":"34","author":"Courivaud","year":"2014","journal-title":"Perit Dial Int"},{"key":"R108-20250619","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000380915","article-title":"Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review.","volume":"5","author":"Lu","year":"2015","journal-title":"Cardiorenal Med"},{"key":"R109-20250619","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000430084","article-title":"Peritoneal dialysis for chronic congestive heart failure.","volume":"40","author":"Fran\u00e7ois","year":"2015","journal-title":"Blood Purif"},{"key":"R110-20250619","doi-asserted-by":"crossref","first-page":"bcr2013008992","DOI":"10.1136\/bcr-2013-008992","article-title":"Peritoneal catheter for massive cardiac ascites.","volume":"2013","author":"Aisenberg","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R111-20250619","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ehf2.12074","article-title":"Permanent catheter drainage system for palliation of diuretic-resistant cardiac ascites.","volume":"3","author":"Bevan","year":"2016","journal-title":"ESC Heart Fail"},{"key":"R112-20250619","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure.","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"R113-20250619","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"R114-20250619","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/CCM.0b013e3181958710","article-title":"Unexplained hypotension: the spectrum of dynamic left ventricular outflow tract obstruction in critical care settings.","volume":"37","author":"Chockalingam","year":"2009","journal-title":"Crit Care Med"},{"key":"R115-20250619","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-8703(94)90633-5","article-title":"Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia.","volume":"128","author":"Leier","year":"1994","journal-title":"Am Heart J"},{"key":"R116-20250619","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.1987.285","article-title":"Captopril inhibits the hydroosmotic effect of ADH in the cortical collecting tubule.","volume":"32","author":"Rouse","year":"1987","journal-title":"Kidney Int"},{"key":"R117-20250619","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0002-9149(86)90066-4","article-title":"Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.","volume":"58","author":"Riegger","year":"1986","journal-title":"Am J Cardiol"},{"key":"R118-20250619","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2014.12.010","article-title":"Hyponatremia in acute decompensated heart failure.","volume":"65","author":"Verbrugge","year":"2015","journal-title":"J Am Coll Card"},{"key":"R119-20250619","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5000432","article-title":"Vasopressin receptor antagonists.","volume":"69","author":"Greenberg","year":"2006","journal-title":"Kidney Int"},{"key":"R120-20250619","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial.","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"R121-20250619","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"R122-20250619","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease.","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:01:33Z","timestamp":1750356093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000310","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,19]]}}}